指南与共识免疫规划卫生政策与健康促进

对脊髓灰质炎病毒输出国建议国际旅行者接种疫苗的临时建议成本效益建模

Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers.
指南 / 共识 · Vaccine · 2017-06-09

该分析评估2014-2016年报告1型野生脊髓灰质炎病毒(WPV1)的国家实施临时建议(TRs)的成本与效益,并考虑多种不确定性。基于规划数据和既往经济分析估算TR成本,通过模拟无TR情况下的潜在WPV1暴发估算效益。

要点

  • 纳入间接成本使成本增加13%,使暴发预防的预期节省增加4%,使预期增量净收益增加3%。
  • 尽管实施TRs成本可观,本研究为在全球消灭疾病后期管理背景下的这些投资提供了健康和经济依据。

核心结论

  • 尽管实施TRs成本可观,本研究为在全球消灭疾病后期管理背景下的这些投资提供了健康和经济依据。

研究设计与样本

  • 基于规划数据和既往经济分析估算TR成本,并通过模拟无TR情况下的潜在WPV1暴发估算TR效益的分析。
  • 模拟使用2004-2013年每报告WPV1病例的WPV1输入暴发速率和范围,以及有活跃TR国家报告的WPV1病例数。

主要发现

  • 纳入间接成本使成本增加13%,使暴发预防的预期节省增加4%,使预期增量净收益增加3%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recognizing that infectious agents readily cross international borders, the International Health Regulations Emergency Committee issues Temporary Recommendations (TRs) that include vaccination of travelers from countries affected by public health emergencies, including serotype 1 wild polioviruses (WPV1s). This analysis estimates the costs and benefits of TRs implemented by countries with reported WPV1 during 2014-2016 while accounting for numerous uncertainties. We estimate the TR costs based on programmatic data and prior economic analyses and TR benefits by simulating potential WPV1 outbreaks in the absence of the TRs using the rate and extent of WPV1 importation outbreaks per reported WPV1 case during 2004-2013 and the number of reported WPV1 cases that occurred in countries with active TRs. The benefits of TRs outweigh the costs in 77% of model iterations, resulting in expected incremental net economic benefits of $210 million. Inclusion of indirect costs increases the costs by 13%, the expected savings from prevented outbreaks by 4%, and the expected incremental net benefits by 3%. Despite the considerable costs of implementing TRs, this study provides health and economic justification for these investments in the context of managing a disease in advanced stages of its global eradication.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Duintjer Tebbens RJ, Thompson KM. Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers. Vaccine. 2017. PMID: 28606811. doi:10.1016/j.vaccine.2017.05.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。